| Neurobehavioral alterations in HIV-1 transgenic rats: evidence for dopaminergic dysfunction LM Moran, RM Booze, KM Webb, CF Mactutus Experimental neurology 239, 139-147, 2013 | 82 | 2013 |
| Sex differences in daily life stress and craving in opioid-dependent patients LM Moran, WJ Kowalczyk, KA Phillips, M Vahabzadeh, JL Lin, ... The American journal of drug and alcohol abuse 44 (5), 512-523, 2018 | 55 | 2018 |
| Time and time again: temporal processing demands implicate perceptual and gating deficits in the HIV-1 transgenic rat LM Moran, RM Booze, CF Mactutus Journal of Neuroimmune Pharmacology 8, 988-997, 2013 | 53 | 2013 |
| Adolescent HIV-1 transgenic rats: evidence for dopaminergic alterations in behavior and neurochemistry revealed by methamphetamine challenge L M Moran, M Y Aksenov, R M Booze, K M Webb, C F Mactutus Current HIV research 10 (5), 415-424, 2012 | 53 | 2012 |
| Modeling deficits in attention, inhibition, and flexibility in HAND LM Moran, RM Booze, CF Mactutus Journal of Neuroimmune Pharmacology 9, 508-521, 2014 | 44 | 2014 |
| HIV-1 proteins dysregulate motivational processes and dopamine circuitry SJ Bertrand, CF Mactutus, SB Harrod, LM Moran, RM Booze Scientific reports 8 (1), 7869, 2018 | 43 | 2018 |
| Neonatal intrahippocampal HIV-1 protein Tat1–86 injection: neurobehavioral alterations in the absence of increased inflammatory cytokine activation LM Moran, S Fitting, RM Booze, KM Webb, CF Mactutus International Journal of Developmental Neuroscience 38, 195-203, 2014 | 28 | 2014 |
| Using ecological momentary assessment to examine the relationship between craving and affect with opioid use in a clinical trial of clonidine as an adjunct medication to … WJ Kowalczyk, LM Moran, JW Bertz, KA Phillips, UE Ghitza, ... The American journal of drug and alcohol abuse 44 (5), 502-511, 2018 | 27 | 2018 |
| Aripiprazole for cocaine abstinence: A randomized–controlled trial with ecological momentary assessment LM Moran, KA Phillips, WJ Kowalczyk, UE Ghitza, DA Agage, DH Epstein, ... Behavioural pharmacology 28 (1), 63-73, 2017 | 27 | 2017 |
| Replication of the pharmacogenetic effect of rs678849 on buprenorphine efficacy in African–Americans with opioid use disorder RC Crist, KA Phillips, MA Furnari, LM Moran, GA Doyle, LF McNicholas, ... The pharmacogenomics journal 19 (3), 260-268, 2019 | 25 | 2019 |
| A gap in time: extending our knowledge of temporal processing deficits in the HIV-1 transgenic rat KA McLaurin, LM Moran, H Li, RM Booze, CF Mactutus Journal of Neuroimmune Pharmacology 12, 171-179, 2017 | 20 | 2017 |
| Selective estrogen receptor β agonists: a therapeutic approach for HIV-1 associated neurocognitive disorders KA McLaurin, LM Moran, RM Booze, CF Mactutus Journal of Neuroimmune Pharmacology 15, 264-279, 2020 | 16 | 2020 |
| The chippers, the quitters, and the highly symptomatic: A 12-month longitudinal study of DSM-5 opioid-and cocaine-use problems in a community sample SW Stull, LV Panlilio, LM Moran, JR Schroeder, JW Bertz, DH Epstein, ... Addictive behaviors 96, 183-191, 2019 | 15 | 2019 |
| Neurorestoration of sustained attention in a model of HIV-1 associated neurocognitive disorders LM Moran, KA McLaurin, RM Booze, CF Mactutus Frontiers in behavioral neuroscience 13, 169, 2019 | 15 | 2019 |
| The role of sensory modality in prepulse inhibition: An ontogenetic study LM Moran, LL Hord, RM Booze, SB Harrod, CF Mactutus Developmental psychobiology 58 (2), 211-222, 2016 | 15 | 2016 |
| The opioid use disorder core outcomes set (OUD–COS) for treatment research: findings from a Delphi consensus study NS Karnik, J Marsden, C McCluskey, RA Boley, KA Bradley, CI Campbell, ... Addiction 117 (9), 2438-2447, 2022 | 13 | 2022 |
| Core outcomes set for research on the treatment of opioid use disorder (COS-OUD): the National Institute on Drug Abuse Clinical Trials Network protocol for an e-Delphi … NS Karnik, CI Campbell, ME Curtis, DA Fiellin, U Ghitza, K Hefner, YI Hser, ... Trials 22, 1-7, 2021 | 12 | 2021 |
| Clonidine increases the likelihood that abstinence can withstand unstructured time in buprenorphine-maintained outpatients WJ Kowalczyk, JW Bertz, LM Moran, KA Phillips, UE Ghitza, DH Epstein, ... Journal of addiction medicine 11 (6), 454-460, 2017 | 12 | 2017 |
| Prenatal IV cocaine: alterations in auditory information processing CF Mactutus, SB Harrod, LL Hord, LM Moran, RM Booze Frontiers in Psychiatry 2, 38, 2011 | 10 | 2011 |
| The NIDA clinical trials network: evolving, expanding, and addressing the opioid epidemic B Tai, R Dobbins, Q Blackeney, D Liu, L Moran Addiction Science & Clinical Practice 16 (1), 28, 2021 | 7 | 2021 |
